Brief: Immunovia Reports Improved Test Performance Of Immray Pancan-D
29/03/2021 20:24
March 29 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA REPORTS IMPROVED TEST PERFORMANCE OF IMMRAY TM
PANCAN-D IN DETECTING EARLY STAGE PANCREATIC CANCER IN HIGH RISK
SYMPTOMATIC PATIENTS
Source text for Eikon: ID:nWkr9sp69p
Further company coverage: IMMNOV.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study